{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:55:23Z","timestamp":1773327323791,"version":"3.50.1"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>This study investigates different barriers preventing a cohort of Egyptian HIV\/HCV coinfected patients from accessing HCV treatment, despite being available and free of charge, aiming to improve the long-term outcomes of coinfected patients and decreasing their liver-related morbidity and mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study included HIV patients who were referred to Kasr Alainy Viral Hepatitis Center to receive HCV treatment and who had to continue pretreatment assessment in order to receive direct acting antiviral agents free of charge. Patients who did not attend within 90 d were questioned via a telephone interview. Questions addressed sociodemographic status, HIV status and the main barriers to accessing healthcare.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 474 HIV\/HCV coinfected patients were eligible for HCV treatment and 223 (47.1%) patients did not complete work-up for HCV treatment. Fear of community stigma concerning HIV\/HCV was the most important barrier to compliance with treatment (73.3%), followed by lack of a supportive work environment and employment opportunities (51.5%), whereas 39.3% stopped follow-up due to the lack of integrated services in the healthcare facility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Managing HCV in HCV\/HIV coinfected patients still represents a major challenge, not only for healthcare providers, but also at a community level, to improve community awareness and manage the major obstacle facing those patients regarding community stigma.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/trstmh\/trab106","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T19:23:52Z","timestamp":1625081032000},"page":"227-232","source":"Crossref","is-referenced-by-count":5,"title":["HCV\/HIV coinfected Egyptian patients: a cross-sectional study of their main characteristics and barriers to HCV treatment initiation"],"prefix":"10.1093","volume":"116","author":[{"given":"Rasha","family":"Eletreby","sequence":"first","affiliation":[{"name":"Endemic Medicine Hepato-Gastroentrology Department, Faculty of Medicine, Cairo University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal","family":"Esmat","sequence":"additional","affiliation":[{"name":"Endemic Medicine Hepato-Gastroentrology Department, Faculty of Medicine, Cairo University, Cairo, Egypt"},{"name":"Endemic Medicine and Hepato-Gastroentrology Department, Badr University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Elsharkawy","sequence":"additional","affiliation":[{"name":"Endemic Medicine Hepato-Gastroentrology Department, Faculty of Medicine, Cairo University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamiaa","family":"Alsehemy","sequence":"additional","affiliation":[{"name":"Endemic Medicine Hepato-Gastroentrology Department, Faculty of Medicine, Cairo University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahma","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Endemic Medicine Hepato-Gastroentrology Department, Faculty of Medicine, Cairo University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3612-0130","authenticated-orcid":false,"given":"Shereen Abdel","family":"Alem","sequence":"additional","affiliation":[{"name":"Endemic Medicine Hepato-Gastroentrology Department, Faculty of Medicine, Cairo University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa","family":"Yousof","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt"},{"name":"Scientific Research Department, Armed Forces College of Medicine (AFCM), Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Cordie","sequence":"additional","affiliation":[{"name":"Endemic Medicine Hepato-Gastroentrology Department, Faculty of Medicine, Cairo University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania M","family":"Lithy","sequence":"additional","affiliation":[{"name":"Endemic Medicine Hepato-Gastroentrology Department, Faculty of Medicine, Cairo University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"issue":"2","key":"2022030221285886300_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL Recommendations on Treatment of Hepatitis C 2018","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"2022030221285886300_bib2","year":"2020"},{"issue":"4","key":"2022030221285886300_bib3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2012.12.026","article-title":"Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997","volume":"144","author":"Van der Helm","year":"2013","journal-title":"Gastroenterology"},{"key":"2022030221285886300_bib4","first-page":"1","article-title":"HIV infection and risk, prevention, and testing behaviors among injecting drug users \u2013 National HIV Behavioral Surveillance System, 20 U.S. cities, 2009","volume":"63","author":"Broz","year":"2014","journal-title":"MMWR Surveill Summ"},{"issue":"9","key":"2022030221285886300_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/0003-4819-158-9-201305070-00604","article-title":"HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study","volume":"158","author":"Kirk","year":"2013","journal-title":"Ann Intern Med"},{"issue":"4","key":"2022030221285886300_bib6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/liv.13266","article-title":"Real life Egyptian experience of efficacy and safety of Simeprevir\/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients","volume":"37","author":"Eletreby","year":"2017","journal-title":"Liver Int"},{"issue":"4","key":"2022030221285886300_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jvh.12481","article-title":"HCV epidemiology in Africa group. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis","volume":"23","author":"Riou","year":"2016","journal-title":"J Viral Hepat"},{"issue":"4","key":"2022030221285886300_bib8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jhep.2017.11.034","article-title":"Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: lessons from the Egyptian experience","volume":"68","author":"Elsharkawy","year":"2018","journal-title":"J Hepatol"},{"issue":"7","key":"2022030221285886300_bib9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/cid\/ciy220","article-title":"Efficacy and safety of glecaprevir\/pibrentasvir in patients coinfected with hepatitis C virus and human immunodeficiency virus type 1: the EXPEDITION-2 study","volume":"67","author":"Rockstroh","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2022030221285886300_bib10","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/cid\/cix111","article-title":"Effectiveness of all-oral antiviral regimens in 996 human immunodeficiency virus\/hepatitis C virus genotype 1-coinfected patients treated in routine practice","volume":"64","author":"Bhattacharya","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2022030221285886300_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/cid\/cix260","article-title":"Sofosbuvir and velpatasvir for the treatment of HCV in patients coinfected with HIV-1: an open-label, phase 3 study","volume":"65","author":"Wyles","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2022030221285886300_bib12","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for testing, managing, and treating hepatitis C virus infection","volume":"67","year":"2018","journal-title":"Clin Infect Dis D"},{"issue":"suppl_1","key":"2022030221285886300_bib13","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/infdis\/jis928","article-title":"Breaking down the barriers to Hepatitis C Virus (HCV) treatment among individuals With HCV\/HIV coinfection: action required at the system, provider, and patient levels","volume":"207","author":"Grebely","year":"2013","journal-title":"J Infecti Dis"},{"issue":"11","key":"2022030221285886300_bib14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/jvh.13343","article-title":"Determinants of stigma among patients with hepatitis C virus infection","volume":"27","author":"Saine","year":"2020","journal-title":"J Viral Hepat"},{"key":"2022030221285886300_bib15","first-page":"1308","article-title":"Needs assessment and coping strategies of persons infected with HIV in Egypt","volume":"14","author":"Kabbash","year":"2008","journal-title":"East Mediterr Health J"},{"key":"2022030221285886300_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.15228","article-title":"Barriers to hepatitis C direct-acting antiviral therapy among HIV\/hepatitis C virus-coinfected persons","author":"Jatt","year":"2021;","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"2022030221285886300_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1177\/0956462419832750","article-title":"Hepatitis C care cascade in HIV patients at an urban clinic in the early direct-acting antiviral era","volume":"30","author":"Ma","year":"2019","journal-title":"Int J STD AIDS"},{"issue":"1","key":"2022030221285886300_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.30171","article-title":"Has access to hepatitis C virus therapy changed for patients with mental health or substance use disorders in the direct-acting-antiviral period?","volume":"69","author":"Jain","year":"2019","journal-title":"Hepatol"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/116\/3\/227\/42685847\/trab106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/116\/3\/227\/42685847\/trab106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T21:30:10Z","timestamp":1646256610000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/116\/3\/227\/6325333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,7,21]]},"published-print":{"date-parts":[[2022,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trab106","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2021,7,21]]}}}